Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings

Shares (Q2 2026)
1,876
Value
$107.3K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BMRN by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,876$107.3K<0.1%−1,797−48.9%ReducedHolders
Q1 20263,673$207.5K<0.1%−114−3.0%ReducedHolders
Q4 20253,787$225.1K<0.1%−1,738−31.5%ReducedHolders
Q3 20255,525$299.2K<0.1%−529−8.7%ReducedHolders
Q2 20256,054$332.8K<0.1%−446−6.9%ReducedHolders
Q1 20256,500$459.5K<0.1%+275+4.4%AddedHolders
Q4 20246,225$409.2K<0.1%−1,165−15.8%ReducedHolders
Q3 20247,390$519.4K<0.1%−4,342−37.0%ReducedHolders
Q2 202411,732$965.9K<0.1%+21+0.2%AddedHolders
Q1 202411,711$1.02M<0.1%−2,519−17.7%ReducedHolders
Q4 202314,230$1.37M<0.1%−51,646−78.4%ReducedHolders
Q3 202365,876$4.06M<0.1%+47,007+249.1%AddedHolders
Q2 202318,869$1.64M<0.1%−7,787−29.2%ReducedHolders
Q1 202326,656$2.59M<0.1%−25−0.1%ReducedHolders
Q4 202226,681$2.76M<0.1%+3,630+15.7%AddedHolders
Q3 202223,051$1.95M<0.1%−577−2.4%ReducedHolders
Q2 202223,628$1.96M<0.1%−5,904−20.0%ReducedHolders
Q1 202229,532$2.28M<0.1%+1,900+6.9%AddedHolders
Q4 202127,632$2.44M<0.1%+2,557+10.2%AddedHolders
Q3 202125,075$1.94M<0.1%−68−0.3%ReducedHolders
Q2 202125,143$2.10M<0.1%−2,908−10.4%ReducedHolders
Q1 202128,051$2.12M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.